Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.2T | 1.1T | 1.0T | 1.1T |
Cost of revenue | 742.2B | 694.2B | 622.4B | 659.1B |
Gross profit | 419.2B | 434.1B | 383.0B | 414.0B |
Operating expense | ||||
Research & development | 22.4B | 27.7B | 29.5B | 27.6B |
Selling general and admin | — | — | — | — |
Other operating expenses | 204.4B | 244.0B | 208.3B | 197.3B |
Operating income | 22.2B | -4.3B | -22.9B | 12.7B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | -7.6B | 17.3B | 20.3B | 20.9B |
Other income expense | — | — | — | — |
Pretax income | 114.7B | 76.7B | 57.7B | 88.7B |
Tax provision | 29.1B | 21.0B | 23.2B | 31.8B |
Net income | 134.3B | 55.8B | 34.5B | 56.9B |
Basic EPS | — | 14.8 | 9.7 | 14.5 |
Diluted EPS | — | 14.8 | 9.7 | 14.5 |
Basic average shares | — | 3.7B | 3.4B | 3.8B |
Diluted average shares | — | 3.7B | 3.4B | 3.8B |
EBITDA | 165.1B | 148.3B | 138.4B | 174.9B |
Net income from continuing op. | — | — | — | — |
Minority interests | 410M | -1.3B | -1.1B | -1.3B |
Preferred stock dividends | 0 | 0 | 0 | 0 |